NRIX

Nurix Therapeutics Inc. Common stock (NRIX)

Stock · NASDAQ · Health Care

$26.21as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$15.15
Industry
Biotechnology: Pharmaceutical Preparations

How Nurix Therapeutics Inc. Common stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$83.98MR&D$316.90M (377%)SG&A$52.74M (63%)Tax$760.0K (1%)NRIX

Source: 10-K filed Jan 28, 2026 · via SEC EDGAR / Finnhub

Nurix Therapeutics Inc. Common stock Competitors

Chosen by industry and closest market cap.

  • NRIX
    Nurix Therapeutics Inc. Common stock
    $26.19
    ▼ 2.57%
    Market cap $2.41BP/E
  • NKTR
    Nektar Therapeutics Common Stock
    $72.57
    ▼ 2.66%
    Market cap $2.38BP/E
    $27.87$109
  • PGEN
    Precigen Inc. Common Stock
    $6.94
    ▼ 3.55%
    Market cap $2.36BP/E
    $2.99$7.72
  • RARE
    Ultragenyx Pharmaceutical Inc. Common Stock
    $25.62
    ▼ 2.46%
    Market cap $2.46BP/E
    $18.29$39.89
  • VERA
    Vera Therapeutics Inc. Class A Common Stock
    $34.19
    ▼ 1.18%
    Market cap $2.31BP/E
    $21.2$56.05
  • TRVI
    Trevi Therapeutics Inc. Common Stock
    $16.78
    ▼ 6.60%
    Market cap $2.54BP/E
    $6.93$20.22
  • KLRA
    Kailera Therapeutics Inc. Common Stock
    $16.26
    ▼ 12.25%
    Market cap $2.24BP/E
    $16.19$28.23

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
115.34M
Total value held
$1.72B
Institutional holders
189
Top holders this quarter
  • Unknown8.93M
  • Unknown7.73M
  • Unknown6.50M
  • Unknown6.35M
  • Unknown5.54M
  • Unknown5.14M
  • Unknown4.93M
  • Unknown4.66M
  • Unknown4.43M
  • Unknown4.10M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.